NEWS & RESOURCES
Estrigenix in the news
Estrigenix Therapeutics, Inc.’s Chief Scientific Officer Karyn Frick PhD featured in Center for Technology Commercialization
Estrigenix Therapeutics, Inc.’s chief scientific officer, Karyn Frick PhD was recently featured in Center for Technology Commercialization talking about the process Estrigenix went through to receive Small Business Innovation Research (SBIR) Ready funding. The SBIR Ready program provided feedback and reviewed multiple proposals from Estrigenix before giving Estrigenix the green…
Estrigenix Therapeutics, Inc. to Attend JP Morgan Meeting
MILWAUKEE (Dec. 14, 2022) – Estrigenix Therapeutics, Inc., a Wisconsin-based, privately held pharmaceutical company leading the way in estrogen biology, is announcing William Donaldson, Ph.D, chief executive officer (CEO) and Patricia Scheller, executive chairwoman, will attend the JP Morgan conference in San Francisco January 9 – 12, 2023. Estrigenix was…
Karyn Frick, Ph.D Featured on ‘Beyond the Paper Gown” Podcast
MILWAUKEE (Dec. 8, 2022) – Estrigenix Therapeutics, Inc., a Wisconsin-based, privately held pharmaceutical company leading the way in estrogen biology, was recently featured on the podcast Beyond the Paper Gown™ hosted by Mitzi Krockover, MD. Karyn Frick, Ph.D, chief scientific officer of Estrigenix spoke with Dr. Krockover regarding Estrigenix’s first-in-class…
Estrigenix Appoints Patricia Scheller as Executive Chairwoman
MILWAUKEE (Dec. 5, 2022) – Estrigenix Therapeutics, Inc., a Wisconsin-based, privately held pharmaceutical company leading the way in estrogen biology, is excited to announce Patricia Scheller as its executive chairwoman. In this role, Scheller will be actively involved in Estrigenix’s business. She will chair the board of directors, act as…
Estrigenix Therapeutics, Inc. honored to have presented at Women’s Healthy Aging Innovation Summit 2022 in San Diego
MILWAUKEE (November 16, 2022) – Estrigenix Therapeutics, Inc., a Wisconsin-based, privately held pharmaceutical company leading the way in estrogen biology, was selected as the winner for the ‘Alzheimer’s & Brain Health’ Category among all presenting companies, for demonstrating the most innovative work in the Alzheimer’s, dementia, and brain health sector….
Estrigenix Therapeutics, Inc. presents new hormone replacement therapy research at the 10th Drug Discovery Strategic Summit
MILWAUKEE (Oct. 25, 2022) – Estrigenix Therapeutics, Inc., a Wisconsin-based, privately held pharmaceutical company leading the way in estrogen biology, is presenting at the 10th Drug Discovery Strategic Summit on Thursday, October 27, and Friday, October 28 at the Grand Hyatt at San Francisco airport, located at 55 South McDonnell Road in…